Article

Befriend your body after cancer

Yoga Bear, a national non-profit organization that provides free yoga services to cancer patients and survivors, is sponsoring an essay contest "Befriending Your Body."On its site, Yoga Bear explains that survivors may feel cancer has taken away a sense of trust or comfort they had with their body before the diagnosis. During treatment, your body may feel like a battlefield. And after treatment, the fear of recurrence or side effects from therapy, such as weight gain or neuropathy, can build resentment.Yoga Bear believes that repairing the relationship with your body after cancer is an important part of the healing process. Exercise, including yoga, can help that process. Through exercise, survivors can improve their mood, energy, weight, and overall health. So, what are you doing to take care of your body? Are you exercising more? Did you quit smoking or swear off nightly desserts? Is there anything you love about your body after cancer? It only takes a minute to share how you are learning to love your body again and we'd love to hear them, too! Essays should be between 100-300 words and can be about one of two topics: 1. What do you love/what are you grateful for about your body? 2. What did you do or going to do to take care of yourself and listen to your body's needs? What have you done to restore trust and acceptance of your body?Winners will have their essays published on the Yoga Bear website and will receive a copy of Yoga Bear adviser Dr. Kelly McGonigal's new book, Yoga for Pain Relief. Read more about the contest at www.yogabear.org/forum/topics/befriend-your-body-an-essay. And hurry, deadline is December 20!

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Dr. Breelyn Wilky urged newly diagnosed GIST patients to seek support from peers and advocacy groups, and to consult experts, even if care stays local.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Image of man with text.
Related Content